Vella AT - Search Results

1

Macrophage polarization and meta-inflammation.

Li C, Xu MM, Wang K, Adler AJ, Vella AT, Zhou B. Li C, et al. Among authors: vella at. Transl Res. 2018 Jan;191:29-44. doi: 10.1016/j.trsl.2017.10.004. Epub 2017 Nov 3. Transl Res. 2018. PMID: 29154757 Free PMC article. Review.

2

Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigen.

Long M, Slaiby AM, Wu S, Hagymasi AT, Mihalyo MA, Bandyopadhyay S, Vella AT, Adler AJ. Long M, et al. Among authors: vella at. J Immunol. 2007 Nov 1;179(9):5669-77. doi: 10.4049/jimmunol.179.9.5669. J Immunol. 2007. PMID: 17947638 Free PMC article.

3

The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death.

Lee SJ, Long M, Adler AJ, Mittler RS, Vella AT. Lee SJ, et al. Among authors: vella at. J Leukoc Biol. 2009 Jan;85(1):175-85. doi: 10.1189/jlb.0408248. Epub 2008 Oct 15. J Leukoc Biol. 2009. PMID: 18923104 Free PMC article.

4

Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation.

Bandyopadhyay S, Long M, Qui HZ, Hagymasi AT, Slaiby AM, Mihalyo MA, Aguila HL, Mittler RS, Vella AT, Adler AJ. Bandyopadhyay S, et al. Among authors: vella at. J Immunol. 2008 Dec 1;181(11):7728-37. doi: 10.4049/jimmunol.181.11.7728. J Immunol. 2008. PMID: 19017962 Free PMC article.

5

CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.

Qui HZ, Hagymasi AT, Bandyopadhyay S, St Rose MC, Ramanarasimhaiah R, Ménoret A, Mittler RS, Gordon SM, Reiner SL, Vella AT, Adler AJ. Qui HZ, et al. Among authors: vella at. J Immunol. 2011 Oct 1;187(7):3555-64. doi: 10.4049/jimmunol.1101244. Epub 2011 Aug 31. J Immunol. 2011. PMID: 21880986 Free PMC article.

6

Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness.

Ngoi SM, St Rose MC, Menoret AM, Smith DE, Tovey MG, Adler AJ, Vella AT. Ngoi SM, et al. Among authors: vella at. Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10486-91. doi: 10.1073/pnas.1202607109. Epub 2012 Jun 11. Proc Natl Acad Sci U S A. 2012. PMID: 22689946 Free PMC article.

7

Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.

Tewalt EF, Cohen JN, Rouhani SJ, Guidi CJ, Qiao H, Fahl SP, Conaway MR, Bender TP, Tung KS, Vella AT, Adler AJ, Chen L, Engelhard VH. Tewalt EF, et al. Among authors: vella at. Blood. 2012 Dec 6;120(24):4772-82. doi: 10.1182/blood-2012-04-427013. Epub 2012 Sep 19. Blood. 2012. PMID: 22993390 Free PMC article.

8

CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion.

St Rose MC, Taylor RA, Bandyopadhyay S, Qui HZ, Hagymasi AT, Vella AT, Adler AJ. St Rose MC, et al. Among authors: vella at. Immunol Cell Biol. 2013 Feb;91(2):173-83. doi: 10.1038/icb.2012.74. Epub 2013 Jan 8. Immunol Cell Biol. 2013. PMID: 23295363 Free PMC article.

9

Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation.

Adler AJ, Vella AT. Adler AJ, et al. Among authors: vella at. Oncoimmunology. 2013 Jan 1;2(1):e22837. doi: 10.4161/onci.22837. Oncoimmunology. 2013. PMID: 23482891 Free PMC article.

10

Striving for synergy: how to improve cancer immunotherapy through multiple agonist costimulation.

Adler AJ, Vella AT. Adler AJ, et al. Among authors: vella at. Immunotherapy. 2013 Dec;5(12):1271-3. doi: 10.2217/imt.13.129. Immunotherapy. 2013. PMID: 24283834 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters